XBiotech Inc. (XBIT)
NASDAQ: XBIT · Real-Time Price · USD
2.810
+0.020 (0.72%)
At close: Sep 10, 2025, 4:00 PM
2.800
-0.010 (-0.36%)
After-hours: Sep 10, 2025, 4:00 PM EDT

XBiotech Statistics

Total Valuation

XBiotech has a market cap or net worth of $85.67 million. The enterprise value is -$69.10 million.

Market Cap85.67M
Enterprise Value -69.10M

Important Dates

The last earnings date was Wednesday, August 13, 2025.

Earnings Date Aug 13, 2025
Ex-Dividend Date n/a

Share Statistics

XBiotech has 30.49 million shares outstanding. The number of shares has increased by 0.08% in one year.

Current Share Class 30.49M
Shares Outstanding 30.49M
Shares Change (YoY) +0.08%
Shares Change (QoQ) n/a
Owned by Insiders (%) 36.43%
Owned by Institutions (%) 11.35%
Float 19.38M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 0.49
P/TBV Ratio 0.48
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 40.16

Current Ratio 40.16
Quick Ratio 39.82
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -73.81

Financial Efficiency

Return on equity (ROE) is -15.23% and return on invested capital (ROIC) is -12.03%.

Return on Equity (ROE) -15.23%
Return on Assets (ROA) -11.59%
Return on Invested Capital (ROIC) -12.03%
Return on Capital Employed (ROCE) -20.90%
Revenue Per Employee n/a
Profits Per Employee -$306,120
Employee Count92
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, XBiotech has paid $25,000 in taxes.

Income Tax 25,000
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -58.77% in the last 52 weeks. The beta is 0.84, so XBiotech's price volatility has been lower than the market average.

Beta (5Y) 0.84
52-Week Price Change -58.77%
50-Day Moving Average 3.02
200-Day Moving Average 3.56
Relative Strength Index (RSI) 35.56
Average Volume (20 Days) 50,568

Short Selling Information

The latest short interest is 303,572, so 1.00% of the outstanding shares have been sold short.

Short Interest 303,572
Short Previous Month 422,171
Short % of Shares Out 1.00%
Short % of Float 1.57%
Short Ratio (days to cover) 7.00

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -36.54M
Pretax Income -30.44M
Net Income -28.16M
EBITDA -34.78M
EBIT -36.54M
Earnings Per Share (EPS) -$0.92
Full Income Statement

Balance Sheet

The company has $152.94 million in cash and n/a in debt, giving a net cash position of $152.94 million or $5.02 per share.

Cash & Cash Equivalents 152.94M
Total Debt n/a
Net Cash 152.94M
Net Cash Per Share $5.02
Equity (Book Value) 173.06M
Book Value Per Share 5.68
Working Capital 151.03M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.09 million and capital expenditures -$567,000, giving a free cash flow of -$25.66 million.

Operating Cash Flow -25.09M
Capital Expenditures -567,000
Free Cash Flow -25.66M
FCF Per Share -$0.84
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

XBiotech does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -0.08%
Shareholder Yield -0.08%
Earnings Yield -33.59%
FCF Yield -30.61%
Dividend Details

Analyst Forecast

Price Target n/a
Price Target Difference n/a
Analyst Consensus n/a
Analyst Count n/a
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2